Regulatory Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical TechnologyThere are already lengthy patient waitlists for the medication on digital health platforms.Metabolic & GLP-1Read full story pharminent June 12, 2026 (Last updated: June 12, 2026) Pharmaceutical Technology There are already lengthy patient waitlists for the medication on digital health platforms. Metabolic & GLP-1 Read full story Post navigation Previous: China’s NMPA approves Akeso’s gumokimab for plaque psoriasisNext: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026